AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Issue

Thursday, November 19, 2020


In The News


Hospital and clinical lab groups are pushing back on an interim final rule that makes reporting COVID-19 data a condition for participating in Medicare, claiming it would place undue financial burdens on their members. “These requirements are a heavy-handed regulatory approach that threatens to expel hospitals from the Medicare program…
Imagine a world in 2030 in which examining a human genome sequence in a research lab becomes as commonplace as conducting a DNA purification. In Nature, Eric D. Green, MD, PhD, and colleagues at the National Human Genome Research Institute (NHGRI) make this forecast and nine others in describing the…
Policy and educational interventions can improve compliance with point-of-care testing (POCT) quality standards, according to a study conducted by members of the Eastern Ontario Regional Laboratory Association (EORLA) in Canada. The investigators writing in Practical Laboratory Medicine discuss how they applied interventions such as meter notifications and policy updates to…

AACC Alert


A novel single-tube multi-marker assay that quantifies six serum proteins exhibited high sensitivity and specificity in identifying preeclampsia (PE), besting a currently used immunoassay in prognostic yield. An article in The Journal of Applied Laboratory Medicine describes these findings.

World View


SelectScience is a leading online information portal for clinical laboratory scientists and a media partner of AACC. The SelectScience expert, scientific editorial team communicates extensively with clinical diagnostic manufacturers, as well as thought-leading clinical scientists and clinicians, to bring you the latest news, interviews, webinars, videos and more. Plus, the…
European investigators surveyed clinical labs on the topic of biomarker testing for heart failure (HF) and found that more labs are offering B-type natriuretic peptide (BNP), with N-terminal pro BNP (NT-proBNP) reigning as the preferred biomarker. Labs also support adjusted cutoff values for age and gender and for patients with…